Physician profile
Matthews Chacko
NPI 1497884647
$6,167.57
in general payments reported to CMS, 2019-2025
8 companies · $2,390 in 2025
The $2,390 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,438 · 2021: $93.23 · 2022: $410 · 2023: $558 · 2024: $279 · 2025: $2,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,967 · Travel and Lodging: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,967.44 |
| Travel and Lodging | $1,259.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,437.61 | 2020 | |
| Medtronic, INC. | $2,361.54 | 2023-2025 | Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $893.81 | 2022-2025 | Avvigo Guidance System, Opticross, Rotapro |
| Abiomed | $209.11 | 2022 | |
| Teleflex LLC | $129.67 | 2023 | Trapliner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.23 | 2021 | |
| Zoll Circulation INC | $27.98 | 2022 | |
| Abbott Laboratories | $14.62 | 2025 | Navitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthews Chacko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.